Influenza Vaccination in Patients with Common Variable Immunodeficiency (CVID)
- PMID: 28983790
- DOI: 10.1007/s11882-017-0749-3
Influenza Vaccination in Patients with Common Variable Immunodeficiency (CVID)
Abstract
Purpose of review: Vaccination against influenza in patients with primary antibody deficiency is recommended. Common variable immunodeficiency (CVID) is the most frequent and clinically relevant antibody deficiency disease and is by definition characterized by an impaired vaccination response. The purpose of this review is to present the current knowledge of humoral and cellular vaccine response to influenza in CVID patients.
Recent findings: Studies conducted in CVID patients demonstrated an impaired humoral response upon influenza vaccination. Data on cellular immune response are in part conflicting, with two out of three studies showing responses similar to healthy controls. Available data suggest a benefit from influenza vaccination in CVID patients. Therefore, annual influenza vaccination in patients and their close household contacts is recommended.
Keywords: Common variable immunodeficiency; Influenza; Primary antibody deficiency; Vaccination.
Similar articles
-
Cellular and humoral influenza-specific immune response upon vaccination in patients with common variable immunodeficiency and unclassified antibody deficiency.Vaccine. 2016 May 5;34(21):2417-2423. doi: 10.1016/j.vaccine.2016.03.091. Epub 2016 Apr 5. Vaccine. 2016. PMID: 27055021
-
Preserved Cellular Immunity Upon Influenza Vaccination in Most Patients with Common Variable Immunodeficiency.J Allergy Clin Immunol Pract. 2020 Jul-Aug;8(7):2332-2340.e5. doi: 10.1016/j.jaip.2020.04.019. Epub 2020 Apr 21. J Allergy Clin Immunol Pract. 2020. PMID: 32330665
-
Cellular immunity in COVID-19 and other infections in Common variable immunodeficiency.Front Immunol. 2023 Apr 26;14:1124279. doi: 10.3389/fimmu.2023.1124279. eCollection 2023. Front Immunol. 2023. PMID: 37180118 Free PMC article. Review.
-
Immunogenicity of Anti-SARS-CoV-2 Vaccines in Common Variable Immunodeficiency.J Clin Immunol. 2022 Feb;42(2):240-252. doi: 10.1007/s10875-021-01174-5. Epub 2021 Nov 17. J Clin Immunol. 2022. PMID: 34787773 Free PMC article.
-
Easy approach to detect cell immunity to COVID vaccines in common variable immunodeficiency patients.Allergol Immunopathol (Madr). 2022 May 1;50(3):101-105. doi: 10.15586/aei.v50i3.583. eCollection 2022. Allergol Immunopathol (Madr). 2022. PMID: 35527662 Review.
Cited by
-
Principles and Challenges in anti-COVID-19 Vaccine Development.Int Arch Allergy Immunol. 2021;182(4):339-349. doi: 10.1159/000514225. Epub 2021 Feb 1. Int Arch Allergy Immunol. 2021. PMID: 33524979 Free PMC article. Review.
-
Vaccination in PADs.Vaccines (Basel). 2021 Jun 9;9(6):626. doi: 10.3390/vaccines9060626. Vaccines (Basel). 2021. PMID: 34207916 Free PMC article. Review.
-
Antigen-Specific CD4+ T-Cell Activation in Primary Antibody Deficiency After BNT162b2 mRNA COVID-19 Vaccination.Front Immunol. 2022 Feb 14;13:827048. doi: 10.3389/fimmu.2022.827048. eCollection 2022. Front Immunol. 2022. PMID: 35237272 Free PMC article.
-
Contribution of immunoglobulin products in influencing seasonal influenza infection and severity in antibody immune deficiency patients receiving immunoglobulin replacement therapy.Front Immunol. 2024 Oct 22;15:1452106. doi: 10.3389/fimmu.2024.1452106. eCollection 2024. Front Immunol. 2024. PMID: 39502688 Free PMC article. Review.
-
COVID-19 Vaccination Compliance and Associated Factors among Medical Students during an Early Phase of Vaccination Rollout-A Survey from Israel.Vaccines (Basel). 2021 Dec 27;10(1):27. doi: 10.3390/vaccines10010027. Vaccines (Basel). 2021. PMID: 35062688 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials